You have no items in your shopping cart.
You have no items in your shopping cart.
| Catalog Number | orb1806301 |
|---|---|
| Category | Antibodies |
| Description | Anti-TNFSF2 / TNFa Reference Antibody is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.36 kDa. |
| Target | TNFSF2 / TNFa |
| Clonality | Monoclonal |
| Conjugation | Unconjugated |
| Reactivity | Human, Primate |
| Concentration | Batch dependent |
| Buffer/Preservatives | 100 mM Proline/Acetic acid 20mM Arginine pH 5.0 |
| Purity | >95% |
| Purification | Protein A |
| UniProt ID | P01375 |
| MW | 145.88 kDa |
| Tested applications | ELISA, FA, FACS, In vivo |
| Expression System | CHO |
| Endotoxins | <0.001 EU/ug |
| Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
| Note | For research use only |

Anti-TNFSF2 / TNFa Reference Antibody (infliximab) on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%.

The purity of Anti-TNFSF2 / TNFa Reference Antibody (infliximab)is more than 100% ;determined by SEC-HPLC.

Immobilized human TNFa; Fc tag at 2 μg/mL can bind Anti-TNFSF2 / TNFa Reference Antibody (infliximab);EC50=0.03538μg/mL.
ELISA, FA, FACS, In vivo | |
Human | |
Monoclonal | |
Unconjugated |
Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.
Login to Submit a Review